Ethical and safety issues of stem cell-based therapy part 30

Stem cell 5


Currently, there are several published or ongoing clinical trials that demonstrated beneficent effects of mesenchymal stem cell-based therapy in the treatment of chronic ischemic cardiomyopathy. Injection of mesenchymal stem cells attenuated fibrosis, induced neo-angiogenesis, enhanced concractility, and improved the quality of life of patients with chronic ischemic cardiomyopathy and implanted cardioverter defibrillator. Haack-Sorensen and co-workers performed demonstrated that intra-myocardial injections of autologous  mesenchymal stem cell significantly improve quality of life, physical limitations and angina stability of patients with chronic coronary artery diseases and refractory angina.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s